AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment - Scorecard - MDSpire

AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment

  • By

  • David Reinecke

  • Nina Müller

  • Anna-Katharina Meissner

  • Gina Fürtjes

  • Lili Leyer

  • Claire Wang

  • Adrian Ion-Margineanu

  • Nader Maarouf

  • Andrew Smith

  • Todd C. Hollon

  • Cheng Jiang

  • Xinhai Hou

  • Abdulkader Al-Shughri

  • Lisa I. Körner

  • Georg Widhalm

  • Thomas Roetzer-Pejrimovsky

  • Matija Snuderl

  • Sandra Camelo-Piragua

  • John G. Golfinos

  • Roland Goldbrunner

  • Daniel A. Orringer

  • Niklas von Spreckelsen

  • Volker Neuschmelting

  • March 17, 2026

  • 0 min

Share

Clinical Scorecard: AI-Powered Label-Free Raman Spectromics for Real-Time Assessment of Spinal Tumors During Surgery

At a Glance

CategoryDetail
ConditionSpinal tumors including meningioma, schwannoma, ependymoma, and metastasis
Key MechanismsStimulated Raman Histology (SRH) imaging combined with AI-based transformer classifier for rapid intraoperative tumor diagnosis
Target PopulationPatients undergoing spinal tumor surgery
Care SettingIntraoperative surgical setting in tertiary academic medical institutions

Key Highlights

  • SpineXtract is the first AI-powered system enabling rapid intraoperative spinal tumor diagnosis using label-free SRH imaging.
  • Achieved 92.9% macro-average balanced accuracy within 5 minutes, outperforming existing brain tumor classifiers by 15.6%.
  • Validated across three international centers with consistent performance and no adverse events related to tissue sampling.

Guideline-Based Recommendations

Diagnosis

  • Utilize stimulated Raman histology (SRH) for label-free, rapid intraoperative imaging without tissue processing.
  • Apply AI-based transformer classifiers optimized for spinal tumor types to improve diagnostic accuracy and speed.
  • Consider SpineXtract as a complementary tool to MRI and frozen section analysis for intraoperative tumor classification.

Management

  • Use rapid intraoperative diagnosis to guide surgical decision-making and immediate treatment strategies.
  • Perform surgical excision as initial therapy for spinal tumors with intraoperative confirmation of tumor type.
  • Avoid delays in treatment by integrating AI-based SRH diagnostics to reduce reliance on time-intensive frozen section pathology.

Monitoring & Follow-up

  • Monitor intraoperative diagnostic accuracy and consistency across institutions to ensure reliable performance.
  • Track patient outcomes including disease recurrence post-surgery to evaluate long-term effectiveness of diagnostic-guided management.

Risks

  • No adverse events reported related to tissue sampling for SRH imaging during surgery.
  • Be aware of potential variability in frozen section diagnostic accuracy (86.6-88.6%) compared to AI-based methods.

Patient & Prescribing Data

44 patients with spinal tumors from diverse demographics across three international tertiary centers.

SpineXtract enables rapid, accurate intraoperative tumor classification facilitating timely surgical management without prior radiation treatment.

Clinical Best Practices

  • Incorporate label-free SRH imaging combined with AI classifiers for real-time intraoperative spinal tumor diagnosis.
  • Ensure multidisciplinary collaboration between surgeons and pathologists to interpret AI-generated heatmaps and diagnostic outputs.
  • Validate AI diagnostic tools across multiple institutions to confirm generalizability and robustness before clinical adoption.

References

Original Source(s)

Related Content